keyword
https://read.qxmd.com/read/38683543/senescent-cafs-mediate-immunosuppression-and-drive-breast-cancer-progression
#1
JOURNAL ARTICLE
Jiayu Ye, John M Baer, Douglas V Faget, Vasilios A Morikis, Qihao Ren, Anupama Melam, Ana Paula Delgado, Xianmin Luo, Satarupa Mullick Bagchi, Jad I Belle, Edward Campos, Michael Friedman, Deborah J Veis, Erik S Knudsen, Agnieszka K Witkiewicz, Scott Powers, Gregory D Longmore, David G DeNardo, Sheila A Stewart
UNLABELLED: The tumor microenvironment (TME) profoundly influences tumorigenesis, with gene expression in the breast TME capable of predicting clinical outcomes. The TME is complex and includes distinct cancer-associated fibroblast (CAF) subtypes whose contribution to tumorigenesis remains unclear. Here, we identify a subset of myofibroblast CAFs (myCAF) that are senescent (senCAF) in mouse and human breast tumors. Utilizing the MMTV-PyMT;INK-ATTAC (INK) mouse model, we found that senCAF-secreted extracellular matrix specifically limits natural killer (NK) cell cytotoxicity to promote tumor growth...
April 17, 2024: Cancer Discovery
https://read.qxmd.com/read/38683507/-evaluation-of-pd-l1-expression-and-intratumoral-lymphocytic-infiltration-in-triple-negative-invasive-breast-carcinoma
#2
JOURNAL ARTICLE
Rina Barrios Barreto, Carlos Silvera Redondo, María Del Pilar Garavito, Laura Ardila Pereira
INTRODUCTION: Triple negative breast cancer endophenotype (TNBC) is one of the least frequent and without therapeutic target; therefore we propose to study the correlation of PD-L1 immune checkpoint with the establishment of tumor microenvironment assessed by intratumoral stromal lymphocyte infiltration (TILS) and its importance in clinical practice. METHODS: A retrospective case-control study was performed, with 31 cases of triple-negative infiltrating breast carcinoma and 57 unmatched controls of Luminal A, Luminal B and HER-2 endophenotype seen in one year...
2024: Medicina
https://read.qxmd.com/read/38683296/clinico-pathologic-factors-and-survival-of-patients-with-breast-cancer-diagnosed-with-de-novo-brain-metastasis-a-national-cancer-database-analysis
#3
JOURNAL ARTICLE
Ali Hijazi, Mohamed Mohanna, Saad Sabbagh, María Herrán, Barbara Dominguez, Kaylee Sarna, Zeina Nahleh
PURPOSE: Patients with Breast Cancer (BC) with Brain Metastasis (BCBM) have poor survival outcomes. We aimed to explore the clinico-pathologic and therapeutic factors predicting the survival in patients with de novo BCBM using the National Cancer Database (NCDB). PATIENTS AND METHODS: The NCDB was queried for patients with BC between 2010 and 2020. Survival analysis with Kaplan-Meier curves and log rank tests were used to find median overall survival (OS) in months (95% CI) across the different variables...
April 29, 2024: Breast Cancer Research and Treatment
https://read.qxmd.com/read/38683161/senescent-cafs-mediate-immunosuppression-and-drive-breast-cancer-progression
#4
JOURNAL ARTICLE
Jiayu Ye, John M Baer, Douglas V Faget, Vasilios A Morikis, Qihao Ren, Anupama Melam, Ana Paula Delgado, Xianmin Luo, Satarupa Mullick Bagchi, Jad I Belle, Edward Campos, Michael Friedman, Deborah J Veis, Erik S Knudsen, Agnieszka K Witkiewicz, Scott Powers, Gregory D Longmore, David G DeNardo, Sheila A Stewart
The tumor microenvironment (TME) profoundly influences tumorigenesis, with gene expression in the breast TME capable of predicting clinical outcomes. The TME is complex and includes distinct cancer-associated fibroblast (CAF) subtypes whose contribution to tumorigenesis remains unclear. Here, we identify a subset of myofibroblast cancer associated fibroblasts (myCAF) that are senescent (senCAF) in mouse and human breast tumors. Utilizing the MMTV-PyMT;INK-ATTAC (INK) mouse model, we found that senCAF-secreted extracellular matrix specifically limits natural killer (NK) cell cytotoxicity to promote tumor growth...
April 29, 2024: Cancer Discovery
https://read.qxmd.com/read/38682908/nitric-oxide-signaling-through-three-receptors-regulates-virulence-biofilm-formation-and-phenotypic-heterogeneity-of-legionella-pneumophila
#5
JOURNAL ARTICLE
Sarah Michaelis, Tong Chen, Camille Schmid, Hubert Hilbi
UNLABELLED: The causative agent of Legionnaires' disease, Legionella pneumophila , is an environmental bacterium, that replicates in macrophages, parasitizes amoeba, and forms biofilms. L. pneumophila employs the Legionella quorum sensing (Lqs) system and the transcription factor LvbR to control various bacterial traits, including virulence and biofilm architecture. LvbR negatively regulates the nitric oxide (NO) receptor Hnox1, linking quorum sensing to NO signaling. Here, we assessed the response of L...
April 29, 2024: MBio
https://read.qxmd.com/read/38682577/antiproliferative-efficacy-and-mechanism-of-action-of-garlic-phytochemicals-functionalized-gold-nanoparticles-in-triple-negative-breast-cancer-cells
#6
JOURNAL ARTICLE
Kimaya Meher, Harshad Paithankar, Ramakrishna V Hosur, Manu Lopus
Fabrication of gold nanoparticles (GNPs) with phytochemicals is an emerging green nanotechnology approach with therapeutic implications. Garlic, known for its culinary and medicinal properties, has been extensively investigated for its anticancer properties. Here, we report a method to substantially enhance the antiproliferative potency of garlic by functionalizing its phytochemicals to GNPs and demonstrate a possible mechanism of action of these nanoparticles in the triple-negative breast cancer cell line, MDA-MB-231...
April 29, 2024: Biomedical Materials
https://read.qxmd.com/read/38680498/car-based-immunotherapy-for-breast-cancer-peculiarities-ongoing-investigations-and-future-strategies
#7
REVIEW
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, Jinyu Zhang, Pengyu Zhang, Yiming Yang
Surgery, chemotherapy, and endocrine therapy have improved the overall survival and postoperative recurrence rates of Luminal A, Luminal B, and HER2-positive breast cancers but treatment modalities for triple-negative breast cancer (TNBC) with poor prognosis remain limited. The effective application of the rapidly developing chimeric antigen receptor (CAR)-T cell therapy in hematological tumors provides new ideas for the treatment of breast cancer. Choosing suitable and specific targets is crucial for applying CAR-T therapy for breast cancer treatment...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38680305/reservoir-characteristics-and-formation-model-of-the-bauxite-gas-reservoir-the-benxi-formation-in-the-lx-block-northeast-of-ordos-basin-china
#8
JOURNAL ARTICLE
Shanshan Yu, Zhigang Zhao, Yanhe Zhu, Xiaomin Zhu, Jin Lai, Dan Li, Xiaolin Wang
Recently, horizontal well L47-1CH in the Longdong area of the southwestern Ordos Basin made a significant breakthrough in bauxite natural gas exploration, changing the traditional geological understanding that bauxite could not form effective reservoirs. To further explore the exploration and development potential of bauxite natural gas reservoirs in the northeast of the Ordos Basin, it is urgent to carry out basic geological studies. This paper discusses the sedimentary environment, reservoir characteristics, and formation patterns of the bauxite gas reservoirs in the LX Block using trace elements, thin sections, X-ray diffraction, scanning electron microscopy, conventional physical properties, constant pressure mercury, etc...
April 23, 2024: ACS Omega
https://read.qxmd.com/read/38680292/pembrolizumab-induced-nephrotoxicity-in-a-patient-with-breast-cancer
#9
Samer Alkassis, Kasey Fitzsimmons, Sara Hurvitz
The introduction of immunotherapy has revolutionized the treatment and improved outcomes of multiple types of cancer. Although breast cancer is a less immune-responsive tumor type, the incorporation of pembrolizumab into chemotherapy regimens in the neoadjuvant and first-line metastatic setting for the triple-negative disease has improved outcomes. However, the use of this type of treatment is associated with a spectrum of adverse events. Although rarely affected, kidneys can be a target for immunotherapy, leading to irreversible injury if not recognized and addressed early...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38679747/thrombopoietin-mimetic-stimulates-bone-marrow-vascular-and-stromal-niches-to-mitigate-acute-radiation-syndrome
#10
JOURNAL ARTICLE
Justin Vercellino, Beata Małachowska, Shilpa Kulkarni, Brett I Bell, Shahin Shajahan, Kosaku Shinoda, Gary Eichenbaum, Amit K Verma, Sanchita P Ghosh, Weng-Lang Yang, Paul S Frenette, Chandan Guha
BACKGROUND: Acute radiation syndrome (ARS) manifests after exposure to high doses of radiation in the instances of radiologic accidents or incidents. Facilitating regeneration of the bone marrow (BM), namely the hematopoietic stem and progenitor cells (HSPCs), is key in mitigating ARS and multi-organ failure. JNJ-26366821, a PEGylated thrombopoietin mimetic (TPOm) peptide, has been shown as an effective medical countermeasure (MCM) to treat hematopoietic-ARS (H-ARS) in mice. However, the activity of TPOm on regulating BM vascular and stromal niches to support HSPC regeneration has yet to be elucidated...
April 29, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38679657/real-world-data-of-her2-negative-early-breast-cancer-patients-treated-with-anthracycline-and-or-taxane-regimens-in-japan
#11
JOURNAL ARTICLE
Akihiko Shimomura, Yasuaki Sagara, Ryo Koto, Masakazu Fujiwara, Yuka Kanemura, Hiroshi Kitagawa, Shigehira Saji
BACKGROUND: Anthracycline- and taxane-based chemotherapy regimens are established treatments for human epidermal growth factor receptor (HER)2-negative early-stage breast cancer with high risk of recurrence. This study examined the prevalence of these chemotherapy regimens as perioperative therapy, the patterns of retreatment, and factors influencing prescription choices in Japan. METHODS: This observational cohort study focused on high-risk early-stage breast cancer patients not undergoing anti-HER2 therapy, utilizing data from a hospital-based claims database in Japan spanning from April 2008 to September 2021...
April 29, 2024: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://read.qxmd.com/read/38679331/milligram-scale-assembly-and-nmr-fingerprint-of-tau-fibrils-adopting-the-alzheimer-s-disease-fold
#12
JOURNAL ARTICLE
Pu Duan, Nadia El Mammeri, Mei Hong
In the Alzheimer's disease (AD) brain, the microtubule-associated protein tau aggregates into paired helical filaments (PHFs) in which each protofilament has a C-shaped conformation. In vitro assembly of tau fibrils adopting this fold is highly valuable for both fundamental and applied studies of AD without requiring patient-brain extracted fibrils. To date, reported methods for forming AD-fold tau fibrils have been irreproducible and sensitive to subtle variations in fibrillization conditions. Here we describe a route to reproducibly assemble tau fibrils adopting the AD fold on the multi-milligram scale...
April 26, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38679099/triclocarban-and-triclosan-promote-breast-cancer-progression-in-vitro-and-in-vivo-via-activating-g-protein-coupled-estrogen-receptor-signaling-pathways
#13
JOURNAL ARTICLE
Ting-Ting He, Xin Li, Jie-Zhi Ma, Yuan Yang, Shiye Zhu, Jianhua Zeng, Lin Luo, Yu-Long Yin, Lin-Ying Cao
Triclocarban (TCC) and triclosan (TCS) have been detected ubiquitously in human body and evoked increasing concerns. This study aimed to reveal the induction risks of TCC and TCS on triple negative breast cancer through non-genomic GPER-mediated signaling pathways. Molecular simulation indicated that TCC exhibited higher GPER binding affinity than TCS theoretically. Calcium mobilization assay displayed that TCC/TCS activated GPER signaling pathway with the lowest observed effective concentrations (LOEC) of 10 nM/100 nM...
April 26, 2024: Science of the Total Environment
https://read.qxmd.com/read/38678954/ganoderic-acid-d-attenuates-gemcitabine-resistance-of-triple-negative-breast-cancer-cells-by-inhibiting-glycolysis-via-hif-1%C3%AE-destabilization
#14
JOURNAL ARTICLE
Binbin Luo, Linyi Song, Limiao Chen, Yue Cai, Mingwei Zhang, Shenyi Wang
BACKGROUND: Gemcitabine (GEM) resistance is the primary reason why combination chemotherapy is limited in triple-negative breast cancer (TNBC). Ganoderic acid D (GAD), a natural triterpenoid compound obtained from Ganoderma lucidum, has been shown to have antitumor activities. However, whether GAD can reverse GEM resistance in TNBC requires further investigation. PURPOSE: This study investigated whether and how GAD could reverse GEM resistance in TNBC as an antitumor adjuvant...
April 23, 2024: Phytomedicine
https://read.qxmd.com/read/38678522/determining-individual-suitability-for-neoadjuvant-systemic-therapy-in-breast-cancer-patients-through-deep-learning
#15
JOURNAL ARTICLE
Enzhao Zhu, Linmei Zhang, Yixian Liu, Tianyu Ji, Jianmeng Dai, Ruichen Tang, Jiayi Wang, Chunyu Hu, Kai Chen, Qianyi Yu, Qiuyi Lu, Zisheng Ai
BACKGROUND: The survival advantage of neoadjuvant systemic therapy (NST) for breast cancer patients remains controversial, especially when considering the heterogeneous characteristics of individual patients. OBJECTIVE: To discern the variability in responses to breast cancer treatment at the individual level and propose personalized treatment recommendations utilizing deep learning (DL). METHODS: Six models were developed to offer individualized treatment suggestions...
April 28, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38678188/antimicrobial-susceptibility-patterns-of-urinary-tract-infections-causing-bacterial-isolates-and-associated-risk-factors-among-hiv-patients-in-tigray-northern-ethiopia
#16
JOURNAL ARTICLE
Tsgabu Kahsay, Gebrecherkos Teame Gebrehiwot, Gebreselema Gebreyohannes, Mulugeta Tilahun, Ataklti Gessese, Amlisha Kahsay
BACKGROUND: Urinary tract infections, a prevalent global infectious disease, are clinical issues not well studied in HIV-positive individuals. UTIs have become a global drug resistance issue, but the prevalence and antibiotic susceptibility patterns of UTI-causing bacteria among HIV patients in Tigray, Ethiopia, are poorly understood. This study aims to identify the prevalence of UTI-causing bacteria, their antibiotic susceptibility patterns, and associated risk factors in HIV patients attending ART clinics at Mekelle General Hospital and Ayder Comprehensive Specialized Hospital in Tigray, Northern Ethiopia...
April 27, 2024: BMC Microbiology
https://read.qxmd.com/read/38678139/small-animal-pet-imaging-with-the-68-ga-labeled-ph-low-insertion-peptide-like-peptide-yjl-4-in-a-triple-negative-breast-cancer-mouse-model
#17
JOURNAL ARTICLE
YueHua Chen, ShuangShuang Song, YanQin Sun, FengYu Wu, GuangJie Yang, ZhenGuang Wang, MingMing Yu
BACKGROUND: The aim of this study was to prepare a novel 68 Ga-labeled pH (low) insertion peptide (pHLIP)-like peptide, YJL-4, and determine its value for the early diagnosis of triple-negative breast cancer (TNBC) via in vivo imaging of tumor-bearing nude mice. The novel peptide YJL-4 was designed using a template-assisted method and synthesized by solid-phase peptide synthesis. After modification with the chelator 1,4,7‑triazacyclononane-N,N',N″-triacetic acid (NOTA), the peptide was labeled with 68 Ga...
April 27, 2024: EJNMMI Radiopharmacy and Chemistry
https://read.qxmd.com/read/38678024/loss-of-nedd8-in-cancer-cells-causes-vulnerability-to-immune-checkpoint-blockade-in-triple-negative-breast-cancer
#18
JOURNAL ARTICLE
Irineos Papakyriacou, Ginte Kutkaite, Marta Rúbies Bedós, Divya Nagarajan, Liam P Alford, Michael P Menden, Yumeng Mao
Immune checkpoint blockade therapy aims to activate the immune system to eliminate cancer cells. However, clinical benefits are only recorded in a subset of patients. Here, we leverage genome-wide CRISPR/Cas9 screens in a Tumor-Immune co-Culture System focusing on triple-negative breast cancer (TNBC). We reveal that NEDD8 loss in cancer cells causes a vulnerability to nivolumab (anti-PD-1). Genetic deletion of NEDD8 only delays cell division initially but cell proliferation is unaffected after recovery. Since the NEDD8 gene is commonly essential, we validate this observation with additional CRISPR screens and uncover enhanced immunogenicity in NEDD8 deficient cells using proteomics...
April 27, 2024: Nature Communications
https://read.qxmd.com/read/38677038/nano-inducer-of-ferroptosis-for-targeted-chemotherapy-of-human-triple-negative-breast-carcinoma
#19
JOURNAL ARTICLE
Neena G Shetake, Sourav Kumar Das, Amit Kumar, Badri N Pandey
Triple negative breast carcinoma (TNBC) accounts for 15-20 % of all incident breast cancers (BC) and is known to be highly invasive, has fewer treatment options, and tends to have a worse prognosis. However, due to its biological heterogeneity and diverse clinical and epidemiological behaviors, TNBC lacks a tumor-specific targeted therapy. In the present work we have developed a TNBC-specific targeted nano-delivery agent comprising of a cRGD labeled magneto-liposome (T-LMD) co-encapsulated with oleic acid coated iron oxide nanoparticles (MN-OA) and doxorubicin (Dox) in the liposome bilayer and core, respectively...
April 20, 2024: Biomater Adv
https://read.qxmd.com/read/38677006/treatment-and-survival-of-patients-diagnosed-with-high-risk-hr-her2-breast-cancer-in-the-netherlands-a-population-based-retrospective-cohort-study
#20
JOURNAL ARTICLE
S W M Lammers, M Meegdes, I J H Vriens, A C Voogd, L de Munck, T J A van Nijnatten, K B M I Keymeulen, V C G Tjan-Heijnen, S M E Geurts
BACKGROUND: Several factors may increase the risk of recurrence of patients diagnosed with hormone receptor-positive human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer (BC). We aim to determine the proportion of patients with high-risk HR+/HER2- BC within the total HR+/HER2- BC cohort and compare their systemic treatments and survival rates with those of patients with low- and intermediate-risk HR+/HER2- BC and triple-negative (TN) BC. PATIENTS AND METHODS: Women diagnosed with nonmetastatic invasive HR+/HER2- BC and TNBC in the Netherlands between 2011 and 2019 were identified from the Netherlands Cancer Registry...
April 26, 2024: ESMO Open
keyword
keyword
4622
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.